FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40288511000001108: Carvedilol 6.25mg tablets (Thame Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Dec 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2033651000001112 Carvedilol 6.25mg tablets (Thame Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2033661000001110 Carvedilol 6.25mg tablets (Thame Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Is a Product containing precisely carvedilol 6.25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has specific active ingredient Carvedilol true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Carvedilol 6.25mg tablets (Thame Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Carvedilol 6.25mg tablets (Thame Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start